Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.
about
Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient miceGene therapy for peripheral arterial diseaseProstanoids for critical limb ischaemiaProstanoids for critical limb ischemiaGene therapy for peripheral arterial diseaseGene Therapy for Cardiovascular DiseaseInhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmidAngiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcersNon-coronary atherosclerosisIntracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in ratsVEGF gene therapy: therapeutic angiogenesis in the clinic and beyondGlucose, VEGF-A, and diabetic complicationsReversal of experimental diabetic neuropathy by VEGF gene transferSystems biology of pro-angiogenic therapies targeting the VEGF systemSystems biology of vascular endothelial growth factorsVirus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121).Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.Mouse model of angiogenesisA novel chimeric promoter that is highly responsive to hypoxia and metals.Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantationUpdate on endovascular treatment of peripheral vascular disease: new tools, techniques, and indicationsAngiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationMolecular advances in cardiac and cardiovascular disease.Therapeutic angiogenesis.Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome.Manipulating angiogenesis against vascular disease.The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies.Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia.Noninvasive approaches to peripheral vascular disease. What's new in evaluation and treatment?Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsisLatest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications.Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinasesA Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's DiseaseMyD88 and TRIF mediate divergent inflammatory and regenerative responses to skeletal muscle ischemia.The impact of molecular medicine upon early cardiovascular drug development.The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology.
P2860
Q21144122-2C2224FB-6297-45DB-A2F0-699005FA1942Q24187841-A6A6A5EC-4437-4033-B68E-DDD8212573C7Q24240537-A60544B6-EFA9-421D-BAFA-53541569D0DFQ24246007-98B7F193-CEE0-4CD2-9726-3CC323FF4094Q24246814-B183DB12-615B-4864-99F4-D2BCF07D2D82Q24791063-E159212D-E25B-4208-A140-B81ED214FA6CQ24793412-D9CE893B-E25E-4987-A8C4-4836966DFD65Q24793891-A608A6DA-8EE0-4EC7-AACE-BA4962D02148Q27024872-B1518643-6D09-4F51-9049-B3F2D5D5FA8BQ28212065-EF29A481-6544-4307-A49C-FB435F8DFCE6Q28260984-E1C30160-237C-4B70-A941-9C040465C0C9Q28362039-C061F829-7A12-494B-B18E-D67616AF2F90Q28364512-787F185C-BD18-48FB-BE48-093CDC064E3DQ30430112-E1ED0F39-674F-4B2E-A872-945ABAAAE954Q30438979-BBE50E02-3768-48BB-8CF5-87FEFC8A5CF6Q30489689-5FDB6EB5-B464-4EEB-AFAB-C76D26239850Q30636655-2EDAA126-B601-4FE7-BA4D-B2978BE77862Q30664734-B03692BC-EBD5-41EE-AD61-D8F651DF2476Q30758542-7A51AECD-C071-40FF-BBDE-AE751D74FF6CQ30876047-4D9A537F-492E-4B16-8DC9-ECA0AE64A862Q32061166-C66BCCD7-3A15-4E0B-B77A-339B3992E6EEQ33233475-FDEDF7B1-271B-483D-B50F-953F57124EFEQ33455791-9936BED4-A111-477E-BE2F-9B7355742AEBQ33581071-40F2CC31-F62B-4FAD-A73E-A5E518E06F63Q33606829-9DB0806A-67B7-44F3-AD15-78DB175A3EBDQ33641514-E871333E-1690-4436-A9BB-35CFC4301F78Q33651225-8F10D437-DF46-434F-B1A6-AEBD6C45E386Q33652551-769B2D5C-38D8-4944-B623-4311AD20AB2AQ33673511-7137961E-889F-49D1-9C8D-6566CE6837EBQ33682785-E8CA6433-8672-4C83-A10D-73A713EBC9E4Q33713495-95C8DA62-C492-4E43-A344-9A2231521AEBQ33736758-C9BF8520-4127-4104-B397-B95778900D0FQ33750051-3F469C0D-DEB9-47DE-9E3D-2F2607F4F8ACQ33830892-75A863C0-412C-4580-A765-E37E59540D81Q33854827-906CF4A2-18F7-4B1E-BD5A-DB4436F7C0F5Q33890319-4D8F3587-CD96-46AE-9D8E-4A912D9B7882Q33901995-FAF26363-9228-4A12-A052-8138C411C574Q33902855-F082F3D1-B76F-41EC-A6C3-7FEDF399B4BCQ33962018-19439389-56BF-4C2E-9346-A11062200DC1Q33985217-494EEF3F-D53D-4B4F-B925-85C0E67CE5FF
P2860
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Constitutive expression of phV ...... s with critical limb ischemia.
@en
Constitutive expression of phV ...... s with critical limb ischemia.
@nl
type
label
Constitutive expression of phV ...... s with critical limb ischemia.
@en
Constitutive expression of phV ...... s with critical limb ischemia.
@nl
prefLabel
Constitutive expression of phV ...... s with critical limb ischemia.
@en
Constitutive expression of phV ...... s with critical limb ischemia.
@nl
P2093
P1433
P1476
Constitutive expression of phV ...... s with critical limb ischemia.
@en
P2093
Baumgartner I
P304
P356
10.1161/01.CIR.97.12.1114
P407
P577
1998-03-01T00:00:00Z